A recent report on Migraine Drugs Market provides a detailed analysis on the industry size, revenue forecasts and geographical landscape pertaining to this business space. Additionally, the report highlights primary obstacles and latest growth trends accepted by key players that form a part of the competitive spectrum of this business.
Migraine Drugs Market is valued around USD 1851.23 Million in 2018 and expected to reach USD 2375.62 Million by 2025 with the CAGR of 3.37% over the forecast period.
Migraine is a neurological disorder leading to severe headache coupled with nausea, vomiting and disturbed vision. It is most common in females as compared to males. Severe pain in head can be triggered by any means such as light, medicines, salty food, hormonal changes and others. In migraine headache starts from one side of the head and slowly travels around the other side.
Key Players for Global Migraine Drugs Market Reports–
Global migraine drugs market report covers prominent players like AstraZeneca Plc., Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Alder Biopharmaceuticals Inc., GlaxoSmithKline plc, Eli Lilly & Co., Allergan Plc., Novartis AG, Merck & Co., Inc., Valeant Pharmaceutical International, Inc., Eisai Co., Ltd., Janssen Pharmaceutical Company (Johnson & Johnson), Pfizer, Inc., Zosano Pharma Corporation, Avanir Pharmaceuticals, Inc., and others.
North America is Expected to Dominate the Migraine Drugs Market
North America is expected to dominate the market in the forecast period. The growth is attributed to the high prevalence of migraine coupled with advanced healthcare facilities and high per capita income. Europe is expected to the second largest growing region followed by Asia Pacific over the forecast period. Asia Pacific is expected to be the fastest growing region over the forecast period owing to the large patient pool, rapidly growing demand for generic and branded migraine drugs, low-cost production of drugs and growing disease awareness. Latin America, Middle East and Africa are emerging market expected to present significant growth over the forecast period.
Key Benefits for Global Migraine Drugs Market Reports –
Migraine Drugs Market Segmentation –
By Drug Class Analysis
Abortive Medicine, Preventive Medicine
By Route of Administration
Oral, Injection, Others
By Distribution Channel
Hospital-based Pharmacies, Retail Pharmacies, Online Pharmacies, Other
Get Sample Copy of This Premium Report @ https://brandessenceresearch.com/requestSample/PostId/43
Interested in this report?